Stephens Investment Banking Expands Healthcare and Life Sciences Capabilities with Two Senior Bankers


LITTLE ROCK, Ark., September 19, 2022–(BUSINESS WIRE)–Stephens, an independent financial services company, today announced that Matt Dormer and Chris Cooley will join the company’s Investment Banking division as managing directors to focus on health and life sciences. Mr. Dormer joins Stephens from another company while Mr. Cooley is leaving Stephens’ equity research team.

“Stephens continues to strengthen our offering in health and life sciences, and the addition of Matt and Chris represents a substantial expansion of the group’s coverage and capabilities. We are very pleased to have them on the team,” said Brad Eichler, Senior Vice President and Head of Investment Banking.

Mr. Dormer has over 20 years of experience in the biotechnology industry. Prior to joining Stephens, he was an investment banker at Oppenheimer & Co., Laidlaw & Co and Summer Street Research Partners. Mr. Dormer began his financial career in equity research at Fulcrum Global Partners covering the biotechnology sector before moving into investment banking. Mr. Dormer holds a BS in Biology from Davidson College and an MBA from Northeastern University. He will be based at Stephens’ office in Boston.

Mr. Cooley has over 28 years of experience and joined Stephens in 2010 to lead coverage of the medical device and hospital supplies industry. Mr. Cooley began his professional career with Dean Witter and worked for Cargill, Morgan Keegan, SunTrust Equitable Securities and FTN Equity Capital Markets. He was recognized by The Wall Street Journal and FinancialTimes for the accuracy of his financial insights and has presented at several corporate events. Mr. Cooley holds a Bachelor of Science in Economics from the University of Arkansas and a Masters of Business Administration from the University of Tennessee. He will be based at Stephens’ office in Little Rock.

Stephens’ Health and Life Sciences team creates innovative solutions for companies that produce equipment and therapies, provide care and support medical facilities.

About Stephen
“Stephens” (the brand name of the company) is a leading family-owned investment company which includes Stephens Inc. (Member NYSE/SIPC), Stephens Investment Management Group, LLC, Stephens Insurance, LLC, Stephens Capital Partners LLC and Stephens Europe Limited (Registered Office: 12 Arthur Street, London, EC4R 9AB, registration number 8817024), which is authorized and regulated by the Financial Conduct Authority. © 2022 Stephens. For more information, visit

See the source version on


Chenoa Taitt, Stephens Inc.
212-891-1742 / [email protected]

Creighton Abrams, Stephens Inc.
212-891-1712 / [email protected]


About Author

Comments are closed.